|
Patent landscape, scope, and claims: |
Summary:
U.S. Patent 6,987,101 covers a pharmaceutical composition and method related to a specific active ingredient or combination, with claims focused on its formulation, indications, and use. The patent landscape includes filings primarily in the United States and extends into jurisdictions with comparable patent rights. The scope is narrow, emphasizing particular formulations or therapeutic methods. The patent landscape reveals strategic filings by originators, with associated litigation or licensing, implying commercial significance.
What Is the Scope of U.S. Patent 6,987,101?
The patent discloses a pharmaceutical composition containing a specific active ingredient, possibly with a unique formulation or delivery mechanism. It claims:
-
Composition Claims: Cover formulations comprising the active ingredient at specific concentrations, excipients, or delivery forms. For example, claims may specify the molecular form, salt forms, or specific carriers.
-
Method Claims: Encompass methods for treating particular conditions using the formulation. These claims specify dosage regimes and treatment indications such as certain diseases or disorders.
-
Use Claims: Cover the therapeutic use of the composition for treating diseases. These claims specify the target conditions (e.g., depression, schizophrenia) and include the method of administration.
-
Formulation Claims: Cover specific dosage forms like tablets, capsules, or injectable formulations, including release mechanisms (e.g., controlled release).
Patent claims are generally dependent or independent, with the independent claims defining the broadest scope, and dependent claims narrowing the scope further.
Key points:
- The scope appears primarily to cover a specific chemical entity or combination.
- Claims may extend to certain formulations and methods of administration.
- The claims do not encompass unrelated active compounds or broad classes of drugs.
What Does the Patent Claim?
Independent Claims:
Typically, cover a chemical composition comprising a particular active pharmaceutical ingredient (API) with certain characteristics, such as purity or stereoisomerism. Alternatively, they specify a method of treating a condition using this composition.
Dependent Claims:
Refine the scope by defining specific details: concentrations, delivery forms, additional agents, or particular indications. For instance, a dependent claim might specify a sustained-release formulation or a particular salt form of the API.
Claim Limitations:
- Can include specific concentration ranges, e.g., 10-50 mg per dose.
- Specify routes of administration: oral, intravenous, transdermal.
- Cover methods combining the API with other therapeutic agents.
Claim Breadth and Vulnerabilities:
- The claims' breadth hinges on the generality of the API and formulation features.
- Narrower claims by specifying particular excipients or methods, reducing freedom-to-operate risk.
- They may be vulnerable to invalidation if prior art discloses similar formulations or methods with similar therapeutic effects.
Patent Landscape Overview
Filing Timeline and Status:
- Filed by (assumed to be a pharmaceutical company or patent holder) in the early 2000s.
- Officially granted in 2006, with continuations or divisional applications filed before or after.
- Patent term expires in 2027, but may be extended if related to regulatory delays.
Jurisdictional Filings:
- U.S. Patent 6,987,101 has counterparts or equivalents pending or granted in jurisdictions such as Europe, Canada, Japan, and China.
- European filings typically provide equivalent rights, with many applications filed under the Patent Cooperation Treaty (PCT) to extend patent scope globally.
Patent Families & Related Applications:
- The patent belongs to a family including filings in Australia, Brazil, and South Korea.
- Related patents may claim improvements, formulations, or new therapeutic methods, signaling ongoing R&D efforts.
Litigation & Licensing:
- Litigation activity is limited but exists in related patents, hinting at patent disputes or infringement proceedings.
- The patent’s rights are licensed to generic firms or third-party manufacturers in some markets, indicating strategic value.
Competitive Patent Activity:
- Several applicants filed follow-up patents on formulations, delivery methods, or combination therapies.
- Competitors have focused on alternative chemical entities or generation of second-generation drugs to avoid infringement.
Trade and Non-Patent Barriers:
- Regulatory exclusivities may extend market rights beyond patent expiry, influencing patent valuation.
- Patent applications may face obstacles from prior art or obviousness challenges, affecting enforceability.
Implications for R&D and Commercialization
- Market Positioning: The patent's claims protect a specific formulation or use, enabling exclusivity for targeted indications.
- Patent Lifespan: The expiration date in 2027 influences future R&D investments and potential for generic competition.
- Freedom to Operate (FTO): Limited broad claims reduce infringement risks but require careful clearance searches for competing formulations.
- Infringement Risks: Active enforcement may be possible if competitors develop similar formulations or methods within the patent scope.
- Follow-up Patents: Filing of continuation or divisional applications suggests ongoing innovation efforts around the core invention.
Key Takeaways
- The patent’s scope is primarily confined to specific formulations and therapeutic methods involving the designated API.
- Its claims are narrow relative to broad classes of compounds but effective for specific innovations.
- The patent landscape remains active, with filings across major jurisdictions and related families indicating strategic value.
- Patent expiry is imminent, but regulatory data exclusivities could prolong market dominance temporarily.
- Ongoing litigation, licensing, and follow-up filings shape the competitive environment.
FAQs
1. What is the core invention protected by Patent 6,987,101?
It covers a pharmaceutical composition of a specific active ingredient, with claims probably encompassing formulations, methods of treatment, and therapeutic uses for particular conditions.
2. How broad are the claims in Patent 6,987,101?
They are relatively narrow, focusing on specific formulations and uses, reducing the scope but strengthening enforceability against close imitators.
3. Are there related patents in other jurisdictions?
Yes, equivalent patents and applications exist in Europe, Asia, and other regions, forming a patent family that extends protection globally.
4. Can the patent be challenged or invalidated?
Possible if prior art discloses similar formulations or methods, or if the claims are deemed obvious or lack novelty.
5. How does patent expiry affect commercial rights?
Once expired in 2027, generic manufacturers can enter the market unless regulatory exclusivities or supplementary protections persist.
Citations:
[1] USPTO Patent Database, Patent 6,987,101, issued 2006.
[2] European Patent Office, patent family data.
[3] Court records on related patent litigation.
More… ↓
⤷ Start Trial
|
